Stay informed with null’s coverage and analysis for Fortune.

Page 4 of 12

  • Sam Waksal is no stranger to biopharma controversy.Tech

    Theranos’ Elizabeth Holmes Says the Company Will “absolutely” Get FDA Approval

    By
  • A Walgreen Co. store in Oak Park, Ill.Leadership

    Walgreens-Rite-Boots-Aid-Alliance: Trust us, it will work!

    By
  • Jeff Smisek, the former CEO of UnitedLeadership

    CEO succession: Is anyone in charge?

    By
  • Henry Kissinger And Charlie Rose Mark The 70th Anniversary Of VE DayLeadership

    Theranos’ board: Plenty of political connections, little relevant expertise

    By
  • Malala Yousafzai holds her Nobel Peace Prize medal last December.Leadership

    How to help Malala and clean your closet at the same time

    By
  • Ellen KullmanLeadership

    Who had a better day: Ellen Kullman or Jack Dorsey?

    By
  • Gavin McClurg, CEO of Offshore Odysseys

    Paragliding across the Alps: ‘A suffer-fest like no other’

    By
  • Corn ear on glass

    The GMO controversy: Time to move on?

    By
  • DBL Partners Nancy Pfund and Fortune's Adam Lashinsky at Brainstorm E 2015

    Solar: It’s baaacck

    By
  • Pope Francis Addresses Joint Meeting Of U.S. CongressLeadership

    What separates Pope Francis from Volkswagen and Donald Trump

    By
  • VW shares plunge after carmaker admits cheating in emissions tesLeadership

    Dear Volkswagen: Exaggeration? Not so bad. Deception? Never okay

    By
  • SABMiller USA 2013Credit: Tom Parker/OneRedEyeImage is copyrightedLeadership

    Will this Brazilian trio eventually control everything you eat and drink?

    By
  • Angela Ahrendts photographed in Miami Apple store. 2015MPW

    What the heck is Angela Ahrendts doing at Apple?

    By
  • Ron Johnson at Enjoy's Bay Area officesLeadership

    Ron Johnson’s latest act? Online retail with a side of personal service

    By
  • Ernst & Young Strategic Growth ForumLeadership

    Will A.G. Lafley’s second handover at P&G go better than the first?

    By